Oligodendroglioma

Cancer Investigation

Volumn 14, Issue 3, 1996, Pages 243-251

  Peterson, Kendra ^a   Cairncross, J Gregory ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; DIAZIQUONE; MELPHALAN;

HISTOLOGY; HUMAN; HUMAN TISSUE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0029742927     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909609012147     Document Type: Review

References (59)

1. Mork SJ, Lindegaard K, Halvorsen TB, et al: Oligodendroglioma: Incidence and biological behavior in a defined population. J Neurosurg 63:881-889, 1985.
2. Nijjar TS, Simpson WJ, Gadalla T, et al: Oligodendroglioma: The Princess Margaret Hospital experience (1958-1984). Cancer 71: 4002-4006, 1993.
3. Shaw EG, Scheithauer BW, O'Fallon JR, et al: Oligodendrogliomas: The Mayo Clinic experience. J Neurosurg 76:428-434, 1992.
4. Russell DS, Rubinstein LJ: Oligodendrogliomas. In: Pathology of Tumours of the Nervous System, 5th ed, edited by DS Russell, LJ Rubinstein, Baltimore, Williams & Wilkins, 1989, pp 172-187.
5. Lee KS, Kelly DL: Primary Oligodendroglioma of the lateral ventricle. South Med J 83:254-255, 1990.
6. Wolf HK, Campos MG, Zentner J, et al: Surgical pathology of temporal lobe epilepsy: Experience with 216 cases. J Neuropathol Exp Neurol 52:499-506, 1993.
7. Pitt MA, Jones AW, Reeve RS, et al: Oligodendroglioma of the fourth ventricle with intracranial and spinal oligodendrogliomatosis: A case report. Br J Neurosurg 6:371-374, 1992.
8. Wilkinson IMS, Anderson JR, Holmes AE: Oligodendroglioma: An analysis of 42 cases. J Neurol Neurosurg Psychiatry 50:304-312, 1987.
9. Lee Y, Tassel PV: Intracranial oligodendrogliomas: Imaging findings in 35 untreated cases. AJR 152:361-369, 1989.
10. Margain D, Peretti-Viton P, Perez-Castillo AM, et al: Oligodendrogliomas. J Neuroradiol 18:153-160, 1991.
11. Bruner JM: Neuropathology of malignant gliomas. Semin Oncol 21:126-138, 1994.
12. Macdonald DR: Low-grade gliomas, mixed gliomas, and oligodendrogliomas. Semin Oncol 21:236-248, 1994.
13. Bishop M, de la Monte SM: Dual lineage of astrocytomas. Am J Pathol 135:517-527, 1989.
14. Yuen ST, Fung CF, Ng TH, et al: Central neurocytoma: Its differentiation from intraventricular Oligodendroglioma. Child Nerv System 8:383-388, 1992.
15. Allegranza A, Pileri S, Frank G, et al: Cerebral ganglioglioma with anaplastic oligodendroglial component. Histopathology 17:439-441, 1990.
16. Shankar SK, Rao TV, Srivastav VK, et al: Balo's concentric sclerosis: A variant of multiple sclerosis associated with oligodendroglioma. Neurosurgery 25:982-986, 1989.
17. Cruz-Sanchez F, Buller JR, Carboni P, et al: Oligodendrogliomas: A clinical, histological, immunocytochemical and lectin-binding study. Histopathology 19:361-367, 1991.
18. Kros JM, Van Eden CG, Stefano SZ, et al: Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas. Cancer 66:1204-1212, 1990.
19. Sarkar C, Roy S, Tandon PN: Oligodendroglial tumors: An immunohistochemical and electron microscopic study. Cancer 61: 1862-1866, 1988.
20. Kros JM, de Jong AA, van der Kwast, et al: Ultrastructural characterization of transitional cells in oligodendrogliomas. J Neuropathol Exp Neurol 51:186-193, 1992.
21. Weir B, Elvidge AR: Oligodendrogliomas: An analysis of 63 cases. J Neurosurg 29:500-505, 1968.
22. Burger PC, Rawlings CE, Cox EB, et al: Clinicopathologic correlations in the oligodendroglioma. Cancer 59:1345-1352, 1987.
23. Ludwig CL, Smith MT, Godfrey AD, et al: A clinicopathological study of 323 patients with oligodendrogliomas. Ann Neurol 19:15-21, 1986.
24. Sun ZM, Genka S, Shitara N, et al: Factors possibly influencing the prognosis of oligodendroglioma. Neurosurgery 22:886-890:1988.
25. Smith MT, Ludwig CL, Godfrey AD, et al: Grading of oligodendrogliomas. Cancer 52:2107-2114, 1983.
26. Kros JM, Troost D, van Eden CG, et al: Oligodendroglioma: A comparison of two grading systems. Cancer 61:2251-2259, 1988.
27. Winger WJ, Macdonald DR, Cairncross JG: Supratentorial anaplastic gliomas in adults: The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71:487-493, 1989.
28. Shaw EG, Scheithauer BW, O'Fallon JR, et al: Mixed oligoastrocytomas; a survival and prognostic Factor analysis. Neurosurgery 34:577-582, 1994.
29. Kernohan JW, Mayborn RF, Svien HJ, et al: Symposium on new and simplified concepts of gliomas; a simplified classification of gliomas. Proc Staff Meet Mayo Clin 24:71-75, 1949.
30. Daumas-Duport C, Scheithauer B, O'Fallon J, et al: Grading of astrocytomas: A simple and reproductive method. Cancer 62: 2152-2165, 1988.
31. Bello MJ, Vaquero J, de Campos JM, et al: Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors. Int J Cancer 57:172-175, 1994.
32. von Diemling, Louis DN, von Ammon K, et al: Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. Cancer Res 52:4277-4279, 1992.
33. Wu JK, Folkerth RD, Ye Z, et al: Aggressive oligodendroglioma predicted by chromosome 10 restriction fragment length polymorphism analysis: Case study. J Neuro-Oncol 15:29-35, 1992.
34. Ransom DT, Ritland SR, Limmel DW, et al: Cytogenetic and loss of heterogeneity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Genes Chromosomes Cancer 5:348-356, 1992.
35. Ransom DT, Ritland SR, Moertel CA, et al: Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chromosomes Cancer 5:357-374, 1992.
36. Coons SW, Johnson PC, Pearl DK, et al: Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human oligodendrogliomas. Neurosurgery 34:680-687, 1994.
37. Kros JM, van Eden CG, Vissers CJ, et al: Prognostic relevance of DNA flow cytometry in oligodendroglioma. Cancer 69:1791-1798, 1992.
38. Lindegaard K, Mork SJ, Eide GE, et al: Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma. J Neurosurg 67:224-230, 1987.
39. Wallner KE, Gonzales M, Sheline GE: Treatment of oligodendrogliomas with or without postoperative irradiation. J Neurosurg 68:684-688, 1988.
40. Shimizu KT, Tran LM, Mark RJ, et al: Management of oligodendrogliomas. Radiology 186:569-572, 1993.
41. Bullard DE, Rawlings CE, Phillips B, et al: Oligodendroglioma: An analysis of the value of radiation therapy. Cancer 60:2179-2188, 1987.
42. Cairncross JG, Macdonald DR: Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 23:360-364, 1988.
43. Levin VA, Edwards MS, Wright DC, et al: Modified procarbazine, CCNU and vincristine (PCV-3) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat Rep 64:237-241, 1980.
44. Cairncross JG, Macdonald DR: Chemotherapy for oligodendroglioma. Arch Neurol 48:225-227, 1991.
45. Cairncross JG, Macdonald DR, Ramsay DA: Aggressive oligodendroglioma: A chemosensitive tumor. Neurosurgery 31:78-82, 1992.
46. Glass J, Hochberg FH, Gruber ML, et al: The treatment of oligodendrogliomas and mixed oligodendrogliomas-astrocytomas with PCV chemotherapy. J Neurosurg 76:741-745, 1992.
47. Kyritsis AP, Yung WKA, Bruner J, et al: The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 32:365-371, 1993.
48. Soffietti R, Chio A, Mocellini C, et al: Response of oligodendroglial tumors to PCV chemotherapy. Neurology 44 (Suppl 2): A309-A310, 1994.
49. Brown M, Cairncross JG, Vick NA, et al: Differential response of recurrent oligodendrogliomas versus astrocytomas to intravenous melphalan. Neurology 40(Suppl):397-398, 1990.
50. Macdonald DR, Gaspar LE, Cairncross JG: Successful chemotherapy for newly diagnosed aggressive oligodendroglioma. Ann Neurol 27:573-574, 1990.
51. Caimcross G, Macdonald D, Ludwin S, et al: Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol (in press).
52. Saarinen UM, Pihko H, Makipernaa A: High-dose thiotepa with autologous bone marrow rescue in recurrent malignant oligodendroglioma: A case report. J Neuro-Oncol 5:57-61, 1990.
53. Mason WP, DeAngelis LM: Procarbazine, CCNU, vincristine (PCV) chemotherapy (CT) for benign oligodendroglioma. Neurology 44(Suppl 2):A262-A263, 1994.
54. Natelson SE, Dyer ML, Harp DL: Delayed CSF seeding of benign oligodendroglioma. South Med J 85:1011-1012, 1992.
55. Van Velthoven V, Calliauw L, Caemaert J: Intramedullary spread of a cerebral oligodendroglioma. Surg Neurol 30:476-481, 1988.
56. Balko MG, Blisard KS, Samaha FJ: Oligodendroglial gliomatosis cerebri. Hum Pathol 23:706-707, 1992.
57. Macdonald DR, O'Brien RA, Gilbert JJ, et al: Metastatic anaplastic oligodendroglioma. Neurology 39:1593-1596, 1989.
58. Taphoom MJB, Neimans JJ, Snoek FJ, et al: Assessment of quality of life in patients treated for low-grade glioma: A preliminary report. J Neurol Neurosurg Psychiatry 55:372-376, 1992.
59. Kleinberg L, Wallner K, Malkin MG: Good performance status of long-term disease-free survivors of intracranial gliomas. J Radiat Oncol Biol Phys 26:129-133, 1993.